Boost throughput of your antibody testing to help the fight against the pandemic.
* Jääskeläinen AJ, et al. Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples. Eurosurveillance, 2020, 25(18), 2000603.
** The combined use of assay, process script and instrument must be validated individually on site by each laboratory.
The Tecan SARS-CoV-2 S1/RBD IgG ELISA is CE-IVD marked in Europe, and may not be available in all countries. Please contact your local Tecan office.